Omnipaque

An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality. .
[PubChem].

Omnipaque - Pharmacology:

Organic iodine compounds block x-rays as they pass through the body, thereby allowing body structures containing iodine to be delineated in contrast to those structures that do not contain iodine. The degree of opacity produced by these compounds is directly proportional to the total amount (concentration and volume) of the iodinated contrast agent in the path of the x-rays. After intrathecal administration into the subarachnoid space, diffusion of iohexol in the CSF allows the visualization of the subarachnoid spaces of the head and spinal canal. After intravascular administration, iohexol makes opaque those vessels in its path of flow, allowing visualization of the internal structures until significant hemodilution occurs.

Omnipaque mini report

Omnipaque NDA
NDA - A product marketed under an approved New Drug Application
Omnipaque INTRATHECAL; INTRAVASCULAR; INTRAVENOUS; ORAL
INTRATHECAL; INTRAVASCULAR; INTRAVENOUS; ORAL
Omnipaque INTRAVASCULAR; INTRAVENOUS; ORAL
INTRAVASCULAR; INTRAVENOUS; ORAL
Omnipaque INTRAVENOUS
INTRAVENOUS
Omnipaque INJECTION
INJECTION
Omnipaque INJECTION, SOLUTION
INJECTION, SOLUTION
Omnipaque HUMAN PRESCRIPTION DRUG
HUMAN PRESCRIPTION DRUG
Start - Stop data
START DATA:
2005-Aug-03
Start - Stop data
STOP DATA
not occurred

Generic name, Overdose, Half Life Omnipaque, Food Interactions, Chemical, etc..

Omnipaque see also FDA report

Brand Names containing Iohexol